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TCTEX1D2 mutations underlie Jeune asphyxiating
thoracic dystrophy with impaired retrograde
intraflagellar transport
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The analysis of individuals with ciliary chondrodysplasias can shed light on sensitive
mechanisms controlling ciliogenesis and cell signalling that are essential to embryonic
development and survival. Here we identify TCTEX1D2 mutations causing Jeune asphyxiating
thoracic dystrophy with partially penetrant inheritance. Loss of TCTEX1D2 impairs retrograde
intraflagellar transport (IFT) in humans and the protist Chlamydomonas, accompanied by
destabilization of the retrograde IFT dynein motor. We thus define TCTEX1D2 as an integral
component of the evolutionarily conserved retrograde IFTmachinery. In complex with several
IFT dynein light chains, it is required for correct vertebrate skeletal formation but may be
functionally redundant under certain conditions.
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T
he malfunction of primary cilia, conserved signalling
organelles present on the surface of most cells, has
emerged as the cause of a growing number of severe
congenital developmental defects1,2. Intraflagellar transport
(IFT), a highly conserved process required for ciliary growth
and signalling, is powered by motors attached to IFT complexes
A and B. The kinesin-2 motor transports cargo along ciliary
microtubules towards the ciliary tip (anterograde IFT). IFT
complexes and other cargo are returned to the base of the cilium
(retrograde IFT) by a specialized cytoplasmic dynein3, termed
dynein 2 in vertebrates and dynein 1b in Chlamydomonas;
(hereafter referred to as ‘IFT dynein’). Chlamydomonas has
been a key organism for elucidating the molecular and
mechanistic basis of IFT. The known subunits of
Chlamydomonas IFT dynein are the homodimer-forming heavy
chain DHC1b, intermediate chains D1bIC1 and D1bIC2 (also
known as FAP163 and FAP133, respectively4), light-intermediate
chain D1bLIC and the light-chain LC8. Human IFT dynein
contains the homologues of these proteins, DYNC2H1, WDR60,
WDR34, DYNC2LI1 and DYNLL1/DYNLL2 (both of which are
LC8 homologues), and probably additional subunits4–10.
However, the regulation, cargo interactions and exact
composition of IFT dynein have remained relatively elusive.
Primary cilia and IFT are required for vertebrate hedgehog
signalling, an important regulator of skeletogenesis11. Mutations
in several IFT dynein components cause short-rib polydactyly
syndromes (SRPS) and Jeune asphyxiating thoracic dystrophy
(JATD; Jeune syndrome), a group of autosomal recessively
inherited, genetically heterogeneous ciliary chondrodysplasias
with overlapping phenotypic features12–16. The spectrum
of disease phenotypes varies in affected individuals but
hallmarks include short ribs and narrow thorax, short limbs,
with sporadic polydactyly and extraskeletal disease including
kidney, liver, eye, heart and brain defects. The underlying
genetic basis of these skeletal ciliopathies also overlaps,
with JATD at the milder end of the JATD/SRPS disease
spectrum17. To date, mutations in 10 genes have been
shown to cause Jeune syndrome, eight leading to classic JATD
with ciliogenesis defects due to IFT dysfunction; these
encode heavy and intermediate IFT dynein subunits
DYNC2H1, WDR34 and WDR60 (refs 12–16), IFT complex B
components IFT80 and IFT172 (refs 18,20), and IFT complex A
components WDR19/IFT144, TTC21B/IFT139 and IFT140
(refs 21–23). Two encode the centriole-associated proteins
CEP120 and CSPP1 (Jeune variants), which are important for
ciliary assembly or function19,24. Disease-causing mutations are
considered hypomorphic since no individuals with SRPS or JATD
were previously shown to carry biallelic loss-of-function
mutations13,17, and homozygosity for ‘null’ alleles is embryonic
lethal in mouse models around midgestation25,26.
Here we report biallelic loss-of-function mutations causing
JATD in the gene encoding TCTEX1D2, an IFT dynein light
chain distinct from DYNLL1/DYNLL2 (LC8). Unusually for the
SRPS/JATD spectrum, affected individuals all carry biallelic ‘null’
alleles where complete loss of protein function is predicted.
Furthermore, the disease phenotype appears incompletely
penetrant. Affinity proteomics indicates that TCTEX1D2/Tctex2b
is an integral component of IFT dynein. We demonstrate a
retrograde IFT defect in TCTEX1D2-deficient human fibroblasts
and Tctex2b-deficient Chlamydomonas cells, and find that
IFT dynein is partially destabilized by loss of Tctex2b in
Chlamydomonas. Compared with mutations in other IFT
dynein components, TCTEX1D2/Tctex2b loss in human,
zebrafish and Chlamydomonas has a modest effect on retrograde
IFT, likely explaining the partially penetrant nature of human
TCTEX1D2 mutations.
Results
Variants in TCTEX1D2 are associated with JATD. Whole-
exome sequencing of 69 individuals from 60 families clinically
diagnosed with JATD identified a homozygous consensus splice
variant (c.113þ 2C4G) in TCTEX1D2 (NM_152773.4, encoding a
dynein light chain) in individual UCL82 II.1 from a
consanguineous Turkish family (Supplementary Fig. 1a).
Reverse transcription PCR (RT-PCR) on RNA derived from
fibroblasts of UCL82 II.1 detected no TCTEX1D2 transcript, sug-
gesting nonsense-mediated decay (NMD) of the mutant transcript
(Supplementary Fig. 2a). All primers used for human genetic
analysis are listed in Supplementary Table 1. Exome copy number
variant analysis revealed a 410-kb homozygous deletion in two
affected siblings (UCL4 II.6 and II.8) from a consanguineous
Arabic family that removes exon 1–2 of TCTEX1D2 including the
start codon, indicating a complete loss-of-function allele
(c.(?_ 142)_247þ ?del) (Supplementary Fig. 3). No other likely
disease-causing variants in known JATD/SRPS-causing genes or
other known ciliary components were detected in these two sib-
lings. The deletion also removes exon 2–5 of neighbouring
TM4SF19 encoding a protein reportedly involved in pancreatic
development but unlikely to be involved in JATD (Supplementary
Fig. 3). Reverse transcription PCR on RNA derived from blood
lymphocytes of individuals UCL4 II.6 and II.8 detected no
TCTEX1D2 transcript, indicating likely NMD of the mutant
transcript (Supplementary Fig. 2b), and no transcripts initiated at
the TM4SF19 start codon continuing into TCTEX1D2 downstream
of the deletion either. Analysis of a further 154 JATD/SRPS exomes
and Sanger sequencing of TCTEX1D2 in 69 additional JATD/SRPS
cases, previously excluded for mutations in known JATD and SRPS
genes, detected compound-heterozygous variants in TCTEX1D2 in
individual INS II.1 from a non-consanguineous French family
comprising a nonsense (c.262C4T; p.Arg88*) and a deletion-
insertion frameshift alteration (c.100delinsCT; p.Val34Leufs*12;
Supplementary Fig. 1b).
The TCTEX1D2 c.113þ 2C4G, c.262C4T and c.100delinsCT
variants are absent from the dbSNP, 1,000 Genomes and EVC
databases. The exon 1–2 deletion is absent from 500 exomes from
the UK10K project and 100 Bedouin control chromosomes
assessed by Sanger sequencing. The c.113þ 2C4G, c.262C4T
and c.100delinsCT variants segregated with the disease phenotype
in affected families as expected (Supplementary Fig. 1). However,
in family UCL4, the exon 1–2 deletion was detected not only in a
third affected individual who died at 2 months due to respiratory
insufficiency (UCL4 II.9) but also in two siblings (UCL4 II.1 and
II.5) for whom no clinical signs of JATD had been documented
(Fig. 1a and Supplementary Fig. 1c,d). When reassessed clinically
with a full X-ray exam, both UCL4 II.1 and II.5 showed mild
brachydactyly and slightly shortened lower limb distal segments;
they are both shorter in stature than their siblings that do not
carry the deletion, and one also had pectus carinatum as a child.
However, in contrast to the other five individuals documented
here as affected with typical clinical features of JATD (short
horizontal ribs, narrow thorax, trident acetabulum with spurs and
polydactyly; Fig. 2 and Table 1), no specific radiological signs of
JATD/SRPS were found in UCL4 II.1 and II.5 (Supplementary
Fig. 4). Thus, while their mild brachydactyly and short stature
could represent a very mild JATD phenotype, or radiological
diagnostic criteria for JATD might have been fulfilled in
childhood, we have no clinical or radiological proof for JATD.
Brachydactyly and short stature can occur with JATD but are not
specific for the condition. We therefore suggest that the
phenotype is not fully penetrant in this family, with the caveat
that we cannot definitively exclude an extremely mild expression
of the JATD phenotype in the two seemingly unaffected
individuals harbouring TCTEX1D2 mutations.
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We examined this further by single-nucleotide polymorphism-
based genome-wide linkage analysis in all members of UCL4. A
high penetrance recessive model coding UCL4 II.1 and II.5 as
unknown identified five homozygous linked regions all with a
logarithm of odds (LOD) score of 2.9, with TCTEX1D2 in the
second largest interval (Supplementary Table 2). Cross-reference
to the exome-sequencing data detected the TCTEX1D2 deletion
and just one other homozygous variant shared between UCL4 II.6
and II.8 in these intervals. The latter was in an untranslated
pseudogene TBC1D3P2 with a minor allele frequency of 1 in 500
in our in-house control database, suggesting it is not causative for
JATD. Considering UCL4 II.1 and II.5 as affected under a
reduced penetrance model (penetrance set at 0.6) generated three
linked regions including one with a LOD score 3.9 across
TCTEX1D2, with no homozygous variants shared between UCL4
II.6 and II.8 in the other intervals (Supplementary Table 3).
Considering UCL4 II.1 and II.5 as unaffected found no linkage to
homozygous variants shared between UCL4 II.6 and II.8 except
the TBC1D3P2 pseudogene variant (LOD score 2.9;
Supplementary Table 4). Finally, considering UCL4 II.1 and II.5
as affected under the high penetrance model identified just one
linked region, a 9.4-Mb locus containing TCTEX1D2 with a LOD
score of 4.1 (Supplementary Table 5). Thus, along with the
expected segregation in two independent families, linkage
modelling supports TCTEX1D2 mutations as disease-causing in
family UCL4.
Functional predictions and evidence of NMD suggest that all
four TCTEX1D2 variants identified are loss-of-function muta-
tions affecting the conserved TCTEX1 domain of the protein
(Fig. 1b). The questionable disease status in individuals UCL4 II.1
and II.5 suggests incomplete penetrance in this family, an
inheritance pattern not previously described for JATD.
Knockdown of tctex1d2 causes a typical ciliopathy phenotype.
TCTEX1D2 function was not previously investigated in verte-
brates and we tested for potential redundancy of the orthologous
gene in zebrafish using oligonucleotide antisense morpholinos to
abrogate transcription. Morpholino oligomers have been used
widely to provide models for Jeune syndrome by transiently
knocking down the expression of the orthologous zebrafish
genes18–20. This approach has been criticized for its inability to
reliably discriminate between specific and non-specific effects
such as developmental delay and cardiac oedema27,28. To increase
reliability, we established that human (NP_689986.2) and
zebrafish (XP_685487.3) TCTEX1D2 proteins are highly
homologous, being 60% identical at 80% BLAST coverage. We
separately tested two different splice-blocking morpholinos and
focussed on phenotypic features described in JATD zebrafish
mutants as well as morphants29–33.
Both morpholinos yielded identical results, producing a dose-
dependent typical ciliopathy phenotype18,20, with ventrally
curved body axis, hydrocephalus, abnormal otoliths and small
eyes (Fig. 3a–h). Loss of transcript was confirmed by RT–PCR
(Supplementary Fig. 5 and Supplementary Table 1). The few
embryos surviving to 4 days post fertilization displayed severe
generalized oedema and pronephric cysts (Fig. 3c,g). Embryos
also showed defects of the craniofacial cartilage as visualized by
alcian blue staining (Fig. 3i,j,m,n), which were comparable to
those observed in other ciliary chondrodysplasia zebrafish models
such as ift80, ift172 and cspp1 (refs 18–20). Immunofluorescence
analysis revealed shorter cilia in the pronephric duct at 24 h post
fertilization (h.p.f.) in tctex1d2morphant embryos compared with
controls (Fig. 3k,o,l,p); however, this difference was no longer
observed at 48 h.p.f. (not shown). This could reflect delayed
ciliogenesis in the morphants or could result from general mild
developmental delay. Cilia in the neural tube appeared normal
(Supplementary Fig. 6).
Loss of TCTEX1D2 causes a retrograde IFT defect. We pro-
ceeded to investigate skin fibroblasts from individual UCL82 II.1
for defects in cilia architecture and IFT disturbance. While the
percentage of ciliated cells was modest but significantly lower for
TCTEX1D2 mutant fibroblasts compared with controls (Fig. 4e),
no significant difference in ciliary length was observed after 24-h
serum starvation, in contrast to the cilia shortening reported in
individuals with mutations in other JATD/SRPS genes12,19
(Fig. 4f). However, there was marked accumulation of the
IFT-particle protein IFT88 in B35% of the ciliary tips of
TCTEX1D2-deficient fibroblasts, compared with o10% of control
fibroblasts (Fig. 4a–d). Cells from an individual previously
reported to carry DYNC2H1 mutations34 showed a very similar
pattern, which indicates a retrograde IFT defect (Fig. 4d).
Chlamydomonas Tctex2b is a light chain of IFT dynein. We
further investigated the role in IFT of Tctex2b, the Chlamydo-
monas homologue of TCTEX1D2 (49% identical at 80% BLAST
coverage; human to Chlamydomonas reciprocal best match
BLAST 9e 36). To determine whether Tctex2b is a subunit of
IFT dynein in Chlamydomonas, we used a new strain expressing
D1bIC2 (homologue of human IFT dynein intermediate chain
WDR34) fused to the haemagglutin-epitope tag (HA). This was
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Figure 1 | TCTEX1D2 deletion in UCL4 and location of identified variants
in TCTEX1D2 protein structure. (a) The absence of TCTEX1D2 exon 1 and 2
in family UCL4 is visualized by PCR of genomic DNA samples from
members of the UCL4 pedigree. TCTEX1D2 exon 4 primers verify the
presence of the gene in samples, but TCTEX1D2 exon 2 primers do not
amplify in some individuals. Children carrying the homozygous exon 1–2
TCTEX1D2 deletion are marked in black (diagnosed with JATD) or grey (two
siblings who were not diagnosed with JATD). The strikethrough indicates
death at 2 months of age; double line indicates consanguineous marriage.
See also Supplementary Fig. 1. (b) Human TCTEX1D2 (shown above, white
boxes indicate untranslated regions (UTR)) consists of five exons encoding
a 142 amino-acid protein (shown below) with a C-terminal TCTEX1 domain
(blue box). The location of the four identified TCTEX1D2 mutations is shown
in the gene (above). Their corresponding location in the protein (below)
shows the TCTEX1 domain will be at least partially lost for all variants
identified in individuals with JATD.
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generated by transforming an insertional mutant defective for
D1bIC2 (dic5-1; Hou et al., manuscript in preparation) with
C-terminal HA-tagged D1bIC2. dic5-1 cells have a severe flagellar
assembly defect that is fully rescued by HA-tagged D1bIC2
(Supplementary Fig. 7), indicating its functional incorporation
into IFT dynein. D1bIC2-HA has a normal distribution in the
cell, is expressed in flagella at approximately normal levels and
sediments normally as part of a complex when the flagellar
membrane-plus-matrix is fractionated on sucrose gradients
(Supplementary Fig. 7). Therefore, D1bIC2-HA behaves like wild-
type D1bIC2 at all levels examined.
We used anti-HA antibody-conjugated beads to immuno-
precipitate D1bIC2-HA protein from the membrane-plus-matrix
fraction of isolated steady-state (that is, non-assembling) flagella
of the D1bIC2-HA strain. SDS–polyacrylamide gel electro-
phoresis (SDS–PAGE) detected bands at BMr 90,000 and
15,000 in the D1bIC2-HA immunoprecipitate that were absent
from the wild-type control (Fig. 5a). Mass spectrometry of excised
bands identified several proteins specific for the D1bIC2-HA
sample, including D1bIC1 (homologue of H.s. WDR60), Tctex2b,
Tctex1 (homologous to both H.s. DYNLT1 and DYNLT3) and
LC8 (homologous to both H.s. DYNLL1 and DYNLL2). LC7a
(homologue of H.s. DYNLRB1 and DYNLRB2) was identified by
nine peptides in the D1bIC2-HA sample and two peptides in the
wild-type control. Western blotting confirmed that D1bIC1,
Tctex2b, Tctex1 and LC8 were specific for the D1bIC2-HA
sample (Fig. 5b–e), and also identified LC7b (also a homologue of
H.s. DYNLRB1 and DYNLRB2) whose peptides were not detected
in the immunoprecipitate because it migrated below the
excised slice (Fig. 5c). Moreover, all detectable D1bIC1, Tctex2b
and Tctex1 were co-immunoprecipitated from the fraction
(Fig. 5b–d). About one-half of the LC7b, about one-quarter of
the DHC1b, D1bLIC and LC8, and trace amounts of FLA10 (a
kinesin-2 heavy chain) and several IFT-particle proteins also were
co-immunoprecipitated with D1bIC2 (Fig. 5b–e).
Tctex2b and Tctex1 have not previously been shown to be
associated with IFT dynein in Chlamydomonas, but they are
known subunits of the axonemal inner arm dynein I1/f, which is
involved in flagellar motility35. Dynein I1/f is present at very low
levels in the membrane-plus-matrix fraction of steady-state
flagella36. Nevertheless, to be sure that the presence of Tctex2b
and Tctex1 in the D1bIC2-HA immunoprecipitate was not due to
contamination by dynein I1/f, we probed blots of the unbound
and bound membrane-plus-matrix with an antibody to IC140, an
I1/f intermediate chain37, and found no IC140 in either the
unbound or bound fractions of either the wild-type or mutant
extracts. We also probed for p28, a subunit common to several
other inner arm dyneins and previously found in the membrane-
plus-matrix fraction of steady-state flagella36. We readily detected
p28 in the unbound fractions, but not in the bound fractions,
indicating that the bound fractions were not contaminated by
these other inner arm dyneins (Fig. 5e). We conclude that
Tctex2b and Tctex1 are novel components of Chlamydomonas
IFT dynein. These results also show that the light chains Tctex2b
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Figure 2 | Clinical features of subjects with TCTEX1D2 mutations. Affected individuals presented with narrow thorax due to shortened ribs
(a–c, UCL82 II.1; g, INS family II.1; j, UCL4 II.6), typical pelvis configuration showing trident acetabulum with spurs (arrows) (d, UCL82 II.1; h, INS family II.1;
k, UCL4 II.6), polydactyly (e,f, UCL82 II.1; l, UCL4 II.6), shortened extremities (a,b, UCL82 II.1) and brachydactyly (i, INS family II.1, asterisks indicate toes).
UCL82 is shown at 38 days in a, c, d and f) and 5.5 yrs in b and e).
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and Tctex1, and intermediate chain D1bIC1 are more closely
associated with D1bIC2 than with the heavy and light-
intermediate chains DHC1b and D1bLIC. It is therefore likely
that D1bIC2, D1bIC1, Tctex1, Tctex2b and LC7b together with
LC8 form a discrete intermediate chain/light-chain complex
within IFT dynein.
Tctex2b is involved in retrograde IFT. With this evidence that
Tctex2b is a subunit of IFT dynein, we investigated whether loss
of Tctex2b affects retrograde IFT. We re-examined a Chlamy-
domonas Tctex2b null strain (here termed tctex2b)35 previously
shown to swim slower than wild-type cells owing to a defect in
inner arm dynein I1/f, but not examined for defects in retrograde
IFT. The tctex2b mutant has normal length flagella at steady state,
but its rate of flagellar assembly is about one-third less than that
of wild type (Fig. 6a). Differential interference contrast (DIC)
microscopy revealed that anterograde IFT velocity is normal, and
anterograde IFT frequency only slightly reduced (Fig. 6b,c).
However, retrograde IFT velocity is B50% reduced, and
retrograde IFT frequency is o25% that of wild type (Fig. 6b,c).
Therefore, loss of Tctex2b has a severe effect specifically on
retrograde IFT, indicating that Tctex2b is required for normal
retrograde IFT.
IFT dynein is destabilized in the absence of Tctex2b. To better
understand why retrograde IFT frequency and velocity are
reduced in the Chlamydomonas tctex2b null mutant, we com-
pared IFT dynein levels in wild-type and tctex2b whole-cell
lysates by western blotting (Fig. 6d). DHC1b, D1bIC2 and
D1bLIC were each reduced by B40–60% in the mutant cells
relative to wild type. These results strongly suggest that IFT
dynein is destabilized in the absence of Tctex2b, with resulting
degradation of the protein complex. In isolated tctex2b flagella,
levels of DHC1b, D1bIC2 and D1bLIC were reduced even further
(Fig. 6e) to onlyB15–25% that of wild type. This likely accounts
for the reduced frequency of retrograde IFT in the mutant.
Western blotting also revealed that the mutant whole cells had
normal levels of IFT-particle proteins (Fig. 6d), but the mutant
flagella had increased amounts of all IFT complex A and B
Table 1 | Summary of clinical findings in individuals with TCTEX1D2 mutations.
Family Ethnicity Consan-
guineous
Patient Mutation Clinical
diagnosis
Thorax Polydactyly Other
skeletal
features
Renal,
liver or
eye
phenotype
Other
remarks
UCL4 UAE
(Yemeni)
Yes II.6 Homozygous
deletion of
exon 1þ 2
JATD Short
horizontal
ribs, narrow
thorax
Foot Trident
acetabulum
with spurs
No Obesity with
hypertension, alive at
16 years, height 10.p.
II.8 Homozygous
deletion of
exon 1þ 2
JATD Short
horizontal
ribs, narrow
thorax
Hand and
foot
Trident
acetabulum
with spurs
No Prolonged
tracheostomy, PEG
tube, alive at 10
years, height o3.p,
on growth hormone
up to 5.p.
II.9 Homozygous
deletion of
exon 1þ 2
JATD Short
horizontal
ribs, narrow
thorax
Hand and
foot
Trident
acetabulum
with spurs
No Died aged 2 months
due to respiratory
failure
II.1 Homozygous
deletion of
exon 1þ 2
NA Normal as a
young adult
No Not evident as a
young adult
(only mild
brachydactyly
and limb
shortening)
No Height o3.p.
No X-ray
documentation
during childhood
performed
II.5 Homozygous
deletion of
exon 1þ 2
NA Normal as a
young adult.
Pectus
carinatum
reported as a
child
No Not evident as a
young adult
(only mild
brachydactyly
and limb
shortening)
No Height o3.p.
No X-ray
documentation
during childhood
performed
UCL82 Turkish Yes II.1 Homozygous
splice site
mutation
c.113þ 2C4G
JATD Short
horizontal
ribs, narrow
thorax
Hand and
foot
Trident
acetabulum with
spurs,
brachydactyly
No Height o3.p.
Alive aged 5.5 years
INS French No II.1 Comp.
heterozygous
c.262C4T,
p.Arg88*;
c.100delinsCT,
p.Val34Leufs*12
JATD Short
horizontal
ribs
No Trident
acetabulum with
spurs,
brachydactyly
No Height 25.-50. p.
Alive at 3 years
JATD, Jeune asphyxiating thoracic dystrophy; NA, not applicable; p, percentile.
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proteins examined (Fig. 6e). This is in agreement with the IFT88
accumulation in fibroblast cilia from affected individual UCL82
II.1 (Fig. 4); both indicate a retrograde IFT defect. If nearly
normal amounts of IFT complexes A and B (apparently
assembled into larger IFT trains; Fig. 6b) are being moved by
fewer dynein motors, it could also explain why IFT velocity is
reduced in the mutant flagella. In addition, since IFT dynein is
reduced much more in the mutant flagella than in the cell body,
the IFT dynein lacking Tctex2b is likely to be imported less
efficiently into flagella than is the complete IFT dynein.
TCTEX1D2 is a component of human IFT dynein. To confirm
that TCTEX1D2 is part of human IFT dynein, we performed
affinity proteomics after expressing SF-TAP (Streptavidin/FLAG
Tandem Affinity Purification)-tagged TCTEX1D2 in HEK293T
cells; cells expressing SF-TAP-RAF1 served as a control. We were
able to identify interactions of TCTEX1D2 with IFT dynein
intermediate chains WDR34 and WDR60, and light chains
DYNLT1, DYNLT3 and DYNLRB1 (Supplementary Table 7). No
peptides from cytoplasmic dynein 1 intermediate chains were
detected, ruling out possible contamination by that dynein. An
interaction between TCTEX1D2 and WDR60 was verified after
overexpression of Flag-tagged TCTEX1D2 and GFP-tagged
WDR60 in HEK293T cells (Supplementary Fig. 8). Identification
of TCTEX1D2, DYNLT1, DYNLT3 and DYNLRB1 as part of the
human IFT dynein is consistent with our finding that the
homologous Tctex2b, Tctex1 and LC7b are part of IFT dynein in
Chlamydomonas, and provides independent evidence that IFT
dynein contains several different light chains. A model of IFT
dynein based on these findings is shown in Fig. 7.
Discussion
Here we report that TCTEX1D2/Tctex2b is a light chain of IFT
dynein in humans and Chlamydomonas, and show for the first
time that it is essential for IFT dynein stability and normal
retrograde (tip-to-base) IFT. In zebrafish, tctex1d2 gene silencing
suggests a role conserved across vertebrates. We show that
biallelic loss-of-function alleles in this gene in humans cause
JATD. In all affected individuals, we identified biallelic
TCTEX1D2 null alleles, which is in striking contrast to JATD
and SRPS individuals carrying mutations in other IFT dynein
genes such as DYNC2H1 (refs 15,16,34,38,39), WDR34 (refs
12,13), WDR60 (ref. 14) or in genes encoding IFT-A21 and IFT-
B18,20 components. These individuals usually carry at least one
missense allele with inheritance restricted to two such
hypomorphic alleles or one hypomorphic allele in combination
with a null mutation13,17,39. Biallelic null alleles also cause early
embryonic lethality in mouse IFT dynein knockouts25,26,40–42,
and complete loss of IFT dynein subunits was thus to date
considered incompatible with embryonic development beyond
midgestation. Our data suggest that TCTEX1D2 is an exception to
this dogma, since all but one child carrying TCTEX1D2 null
mutations survived beyond infancy.
The high survival rate could reflect a milder thorax phenotype
than in individuals with mutations in other IFT dynein genes
 Pronephros Pronephros
Acetylated tubulin + DAPI Acetylated tubulin + DAPI
Acetylated tubulin + DAPIAcetylated tubulin + DAPI
tctex1d2 moControl mo
100 μm 100 μm
100 μm
100 μm
100 μm
100 μm 100 μm 100 μm 100 μm 100 μm
Alcian blue Alcian blue
Alcian blueAlcian blue
50 μm
50 μm
100 μm
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Figure 3 | Knockdown of tctex1d2 in zebrafish leads to a typical ciliopathy phenotype. Whole-mount light microscopy showing control morpholino
(mo)-injected embryos (a–d) and tctex1d2 morphants at 4 days post fertilization (e–h). Compared with controls, knockdown of tctex1d2 results in ventrally
curved body axis (a,e), small eyes (b,f), pronephric cysts (c,g) and otolith defects (d,h). Alcian blue staining of cartilage identifies craniofacial cartilage
defects in tctexd2 morphants (m,n) compared with controls (i,j). Immunofluorescence analysis after staining of cilia at 24 h.p.f. with anti-acetylated tubulin
antibody reveals shorter cilia in the pronephric duct of tctex1d2 morphants (o, magnified in p) compared with control embryos (k, magnified in l); however,
this difference was no longer evident at 48 h.p.f. (data not shown). Scale bars, 100mm (a–j,m,n) or 50mm (k,l,o,p).
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such as DYNC2H1, WDR34 and WDR60 (refs 12–15,34).
Similarly to individuals with mutations in the IFT dynein
heavy-chain gene DYNC2H1 (refs 15,34), individuals with
TCTEX1D2 mutations did not show signs of extraskeletal
disease; however, these phenotypes could still emerge with age.
Two siblings (UCL4 II.1 and II.5) carrying homozygous
TCTEX1D2 mutations did not show overt signs of JATD,
suggesting disease non-penetrance. Both are now young adults,
and it is possible that early JATD radiological features (handlebar
clavicles, trident acetabulum with spurs and cone-shaped
epiphyses) were missed because a full X-ray exam was only
performed in adulthood after we detected the unusual penetrance
pattern. However, in contrast to their three affected siblings, they
also do not exhibit polydactyly or shortened ribs. Although both
are short statured with mildly short digits and lower limbs, more
specific radiological signs of JATD/SRPS were not found.
Together, these clinical findings suggest a less essential role of
TCTEX1D2 in ciliary transport mechanisms compared with other
proteins mutated in JATD and SRPS. Cilia of human fibroblasts
with TCTEX1D2 mutations and tctex1d2 zebrafish morphants
lack gross structural defects, indicating a potentially non-essential
role in vertebrate ciliogenesis. Similarly, flagella of the Chlamy-
domonas tctex2b null mutant are normal length at steady state,
whereas null mutants of IFT dynein subunits DHC1b or D1bLIC
have a severe short flagellar phenotype43–45.
Our studies in Chlamydomonas provide insight into the
molecular mechanism underlying the milder phenotype. Loss of
Chlamydomonas Tctex2b causes IFT dynein instability and a
reduced amount of IFT dynein in flagella; however, surprisingly,
the residual IFT dynein lacking Tctex2b retains enough
functionality to maintain full-length flagella. Thus, it appears
that a key role of Tctex2b is to stabilize IFT dynein. The lower
level of IFT dynein is accompanied by reduced retrograde IFT
velocity and frequency, causing an accumulation of IFT-particle
proteins both in Chlamydomonas flagella and skin fibroblast cilia
from affected individual UCL82 II.1. That Chlamydomonas cells
tolerate some reduction of retrograde IFT is in agreement with
observations that the dhc1b temperature-sensitive mutants
dhc1b-3 and fla24 have reduced amounts of IFT dynein and
reduced retrograde IFT at permissive temperature, yet still
assemble normal length flagella46–48. In the case of the tctex2b
mutant, flagella are formed more slowly than in wild-type cells,
probably reflecting slower recycling of IFT components.
The slower flagellar assembly in the Chlamydomonas tctex2b
mutant, if recapitulated in vertebrates, might explain our
observation that tctex1d2 morphant zebrafish embryos appeared
to have short cilia at 24 h.p.f. but normal length cilia at 48 h.p.f.
Interestingly, this finding, and the normal length cilia and flagella
found in patient UCL82 II.1 fibroblasts and the Chlamydomonas
tctex2b mutant, contrasts with a recent report that short
interfering RNA-mediated depletion of TCTEX1D2 in human
telomerase-immortalized retinal pigment epithelial (hTERT-
RPE1) cells resulted in longer cilia49. However, cilia length
changes, ranging from shorter, normal length or longer than
normal12,18,34, have been reported in cells from JATD patients
with a number of gene defects. Furthermore, WDR34 mutant
patient fibroblasts have shortened cilia12, whereas WDR34 short
interfering RNA knockdown in hTERT-RPE1 results in longer
cilia49. Vertebrate cilia length changes arising from retrograde
IFT perturbations may thus be cell type specific or subject to
experimental variability. These changes are not necessarily
predictable, and therefore do not seem to provide a reliable
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Figure 4 | Loss of human TCTEX1D2 results in retrograde IFT defects. Immunofluorescence analysis using confocal microscopy revealed an
accumulation of IFT88 at the ciliary tips in skin fibroblasts from individual UCL82 II.1 compared with a control (a,b). The accumulation is comparable to that
previously reported in fibroblast cilia from an individual with JATD caused by biallelic variants in DYNC2H1 (ref. 34) (c). IFT88 staining is shown in green,
anti-acetylated tubulin antibody (red) was used for visualization of the ciliary axoneme, anti-pericentrin antibody (white) marks the ciliary base; the IFT88
labeling also is shown separately in the lower panels. Scale bars, 5mm. (d) Fraction of cells with IFT88 accumulation at the ciliary tip, 100 cells analysed for
each condition. (e) The percentage of ciliated cells in the fibroblast sample from individual UCL82 II.1 compared with control fibroblasts as assessed by
counting the number of cilia stained with anti-acetylated tubulin antibody in relation to nuclei stained with DAPI (4,6-diamidino-2-phenylindole, blue
in a–c) in 10 random visual fields in five independent experiments each, revealing a very mild reduction in ciliation for the TCTEX1D2-deficient cells. One
hundred cells were counted per experiment, represented by a single point per experiment. (f) No difference in cilia length between UCL82 II.1 and control
fibroblasts was visualized using anti-acetylated tubulin antibody, 100 cells analysed for each condition. Statistical significance in e and f was measured
using the Student’s t-test, asterisk indicates P value o0.05.
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measure, compared with the direct IFT measurements reported
here that include immunofluorescence imaging of altered
localization of IFT cargos and DIC imaging of IFT velocity.
Although no difference in cilia length was observed in skin
fibroblasts of JATD compared with control individuals in our
study, similar to the Chlamydomonas Tctex2b mutant, any delay
in cilia assembly could have severe consequences during
development if full-length cilia are required for proper
functioning of the hedgehog or other vertebrate ciliary
signalling pathways soon after onset of cilia formation. Since
retrograde IFT is critical for hedgehog signalling11,50, impaired
retrograde IFT even in full-length cilia could be expected to affect
skeletal development, as seen in the TCTEX1D2-mutated JATD
individuals.
The Chlamydomonas Tctex2b mutant swims B30% slower
than wild-type cells owing to defects in axonemal dyneins35.
However, a ciliary motility defect is not the cause of JATD,
because primary ciliary dyskinesia (PCD) patients with ciliary
motility defects do not have JATD symptoms, and multiciliated
cells bearing motile cilia are not present in the tissues affected in
JATD nor in their progenitor cells1. JATD is caused by defects in
primary cilia; primary cilia lack axonemal dyneins.
Proteomic analysis in Chlamydomonas and human cells
confirmed Tctex2b/TCTEX1D2 as a component of IFT dynein
along with intermediate chains D1bIC2/WDR34 and D1bIC1/
WDR60, and a number of light chains. Immunoprecipitation of
Chlamydomonas IFT dynein not only identified Tctex2b but also
Tctex1 and LC7b as novel subunits of IFT dynein, indicating that
these light chains together with LC8, D1bIC2 and D1bIC1 likely
form a light-chain/intermediate chain complex within IFT
dynein, which also may contain subunits not detected by our
methods. Proteomics analysis of HEK293T proteins co-immuno-
precipitated with SF-TAP-tagged TCTEX1D2 likewise identified
DYNLT1 and DYNLT3 (human Tctex1), and additional light
chains in the LC8 and roadblock families (DYNLL2¼ LC8-type 2
and DYNLRB1¼DNLC2A). The light-chain pairs DYNLL1/
DYNLL2 and DYNLRB1/DYNLRB2 have a high sequence
identity of 93% and 77% respectively. This approach did not
identify any peptides specific for DYNLL1 or DYNLRB2, but one
peptide each was identified for DYNLL1/DYNLL2 and
DYNLRB1/DYNLRB2, which could have originated from either
of the two homologous proteins. Furthermore DYNLL1 was
previously confirmed as a light chain of human IFT dynein13.
Therefore, we propose that these subunits are components of an
ancient, highly conserved intermediate chain/light-chain complex
within IFT dynein (Fig. 7). As such, these light chains are strong
candidates for harbouring novel mutations causing JATD.
Dynein complexes fall into two general types based on whether
they contain single or multiple heavy-chain motor units51. Those
with multiple motors all associate with a core group of accessory
proteins including WD-repeat intermediate chains and light
chains in the Dynll/LC8, Dynlt/Tctex1 and Dynlrb/LC7 classes
(axonemal outer dynein arms and inner arm I1/f also include
proteins related to TCTEX1D2/Tctex2, which form a distinct
subfamily within the Dynlt/Tctex1 group51). Our demonstration
that the IFT dynein includes a member of this subfamily suggests
that the presence of TCTEX1D2 is also a conserved defining
feature of these multimotor dyneins, and raises the possibility that
canonical cytoplasmic dynein 1 might also associate with
members of this light chain type under certain circumstances52.
The possible disease non-penetrance in family UCL4 is of
clinical interest. Variable phenotypic severity is well documented
for JATD/SRPS even within families. However, never before to
the extent that individuals can appear clinically unaffected but
carry biallelic loss-of-function variants that cause documented
JATD/SRPS in other family members. Functional redundancy of
TCTEX1D2 with other proteins could explain this, if, for
example, other dynein light chains might in certain conditions
be able to compensate for its loss. Mice carrying Dynll1 mutations
showed possible functional redundancy of IFT dynein light
chains, whereby DYNLL2 may be able to function in place of
DYNLL1 (ref. 53). We looked at single-nucleotide polymorphism
haplotypes across dynein light-chain genes DYNLL1, DYNLL2
and TCTEX1 in individuals UCL4 II.1 and II.5 who carry the
TCTEX1D2 deletion but appear clinically unaffected. Both have
different haplotypes across TCTEX1 compared with their siblings
II.8 and II.9 who display a classical JATD phenotype, but whether
protective alleles could exist in compensatory genes is not clear
(Supplementary Fig. 9).
Alternatively, TCTEX1D2 loss could be attenuated by
individual-to-individual variation in the proteins with which
TCTEX1D2 normally interacts, or in other proteins involved in
IFT dynein stabilization or degradation. Modifier alleles have
been debated as the underlying cause of the phenotypic variability
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Figure 5 | Tctex2b and Tctex1 are in an IFT dynein intermediate
chain/light-chain subcomplex with D1bIC2 and D1bIC1. (a) Flagellar
membrane-plus-matrix fractions from wild-type (WT) cells or cells
expressing D1bIC2-HA were incubated with anti-HA antibody-conjugated
beads. The proteins pulled down by the beads were separated by
SDS–PAGE and silver stained. One band (marked *) between 75 and
100 kDa and several bands around 15 kDa (marked ]) are specific for the
D1bIC2-HA sample. (b–d) Western blots confirming that Tctex2b, Tctex1
and D1bIC1 are specifically co-precipitated with D1bIC2-HA. The unbound
and bound samples were probed with the indicated antibodies. In each
experiment, all of the D1bIC2-HA was immunoprecipitated from the
D1bIC2-HA sample; all of the D1bIC1 (b,d), Tctex1 (b) and Tctex2b (c) was
co-precipitated from the D1bIC2-HA sample. None of these proteins were
pulled down from the WT control. Some but not all of the DHC1b (d),
D1bLIC (b,d), LC7b (c) and LC8 (e) was co-precipitated from the
D1bIC2-HA samples; (d) also shows that only very small amounts of the
IFT-particle proteins or FLA10 were co-precipitated with D1bIC2-HA.
(e) Similar western blot showing that p28 was not co-precipitated with
D1bIC2-HA. In b, d and e, the ratio of unbound: bound protein loaded was
1:4; in c, the ratio was 1:2. All antibodies used for Chlamydomonas protein
analysis are listed in Supplementary Table 6.
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in ciliary chondrodysplasias13,23,34 and other ciliopathies such as
Bardet–Biedl, Joubert and Meckel syndromes; however, this has
remained a challenge to prove in human subjects54,55. Variable
penetrance in autosomal recessive conditions is still quite
unusual, one example being a common CFTR variant that
causes either disease or a normal phenotype depending on its
genetic context56.
It may be relevant that partial suppression of mutations in
genes encoding IFT-particle proteins has been observed
in Chlamydomonas and Tetrahymena57–59; this occurs in
association with stress, suggesting possible involvement of a
chaperone in stabilizing the incomplete IFT particle. Given that a
key role of Tctex2b is to stabilize IFT dynein, the presence or
absence of another protein such as a chaperone that helps
stabilize IFT dynein could determine whether or not a
developmental defect is observed in the absence of Tctex2b.
Interestingly, peptides derived from chaperones were abundant in
our proteomic analysis of TAP-tagged TCTEX1D2 from
HEK293T cells.
In summary, we have identified mutations associated with
a complete loss of TCTEX1D2 causing Jeune syndrome.
TCTEX1D2 mutations are a rare cause of disease affecting
o5% of cases in this study (three affected families identified after
screening of 4300 individuals with JATD/SRPS). There are
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Figure 7 | Proposed model of IFT dynein composition in Homo sapiens
(Hs) and C. reinhardtii (Cr). Left, IFT dynein (dynein 2/1b) is composed of
dynein heavy chains (DYNC2H1(Hs)/DHC1b(Cr); shown in dark grey),
dynein light-intermediate chains (DYNC2LI1(Hs)/D1bLIC(Cr); shown in
light grey) and different dynein intermediate and light chains (coloured,
shown in detail on the right). Right, dynein intermediate chains
(WDR34(Hs)/D1bIC2(Cr) and WDR60(Hs)/D1bIC1(Cr)) interact with
different dynein light-chain subtypes, including TCTEX1D2(Hs)/
TCTEX2b(Cr). Question marks indicate LC7a and DYNLRB2 as unconfirmed
components suggested from our Chlamydomonas and human results.
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important implications for genetic counselling since individuals
carrying TCTEX1D2 mutations appear to have a higher survival
rate than individuals affected by mutations in other IFT dynein
components, and lack extraskeletal symptoms. In humans, fish
and Chlamydomonas, TCTEX1D2 mutations do not confer
changes in gross ciliary structure, but do impair the highly
conserved retrograde IFT machinery. Proteomic analysis provides
evidence that TCTEX1D2/Tctex2b is a component of an
intermediate chain/light-chain subcomplex within IFT dynein.
In Chlamydomonas, the retrograde IFT defect is associated with
instability of IFT dynein; motor stability may be the major role of
Tctex2b since the residual IFT dynein missing Tctex2b retains
some functionality. Our findings that IFT is impaired to a lesser
extent in TCTEX1D2/Tctex2b null cells than in cells carrying null
mutations in other IFT dynein components could explain, in part,
the apparently incomplete penetrance underlying TCTEX1D2
disease. This potentially has future clinical therapeutic implica-
tions, for example, if modulation of other components affecting
the IFT dynein system could be harnessed to attenuate the effects
of a lack of TCTEX1D2 function.
Methods
Patients. Inclusion criteria were the clinical diagnosis of JATD based on clinical
and radiological findings including short ribs with small/narrow thorax and small
ilia with acetabular spurs, handlebar clavicles and brachydactyly. All samples were
obtained with approval of the UCL-ICH/Great Ormond Street Hospital Research
Ethics Committee (08/H0713/82), South Yorkshire Research Ethics Committee
(11/H1310/1) and collaborating institutions with informed consent.
Human Sanger sequencing and PCR. Familial segregation in accordance with a
recessive inheritance pattern was confirmed by Sanger sequencing of PCR
products amplified from genomic DNA samples of all available family members
(SourceBiosciences, Cambridge, UK). For family UCL4, fresh repeat samples were
collected for segregation analysis, indicating no chance of sampling error. For
RT–PCR, the Omniscript kit (Qiagen) was used to make cDNA from total RNA
isolated from lymphocytes or fibroblasts of affected individuals and controls using
Trizol–chloroform extraction. PCR and RT–PCR primers used are listed in
Supplementary Table 1.
Western blotting. Uncropped images of all western blots are included in
Supplementary Fig. 10.
Constructs used in mammalian cells. Mouse WDR60 and human TCTEX1D2
cDNA were obtained from the University of Queensland’s SRC Microarray facility.
A sequence-verified SF-TAP-TCTEX1D2 construct (BC021177.2) containing a
double Streptavidin II and a single FLAG tag was kindly provided by Nicholas
Katsanis (Duke University, Durham, USA). WDR60 was cloned into the GFP-N1
vector by PCR amplification, EcoRI/KpnI digestion and ligation. TCTEX1D2
cloned into a modified pCR3 vector for expression of FLAG-tagged proteins was a
kind gift from Dr Jo¨rg Heierhorst (St Vincent’s Institute of Medical Research,
Melbourne). The human tGFP-taggedWDR34 mammalian expression plasmid was
obtained from OriGene Technologies, Inc. (TrueORF clone RG204288).
Human cell culture. Human fibroblasts obtained by skin biopsy from study
subjects and HEK293T cells (European Collection of Cell Cultures) were cultured
under standard conditions at 37 C and 5% CO2 in DMEM-F12 Glutamax medium
(Life Technologies) with 10% fetal bovine serum (Life Technologies).
Immunofluorescence in mammalian cells and zebrafish. Human fibroblasts
were split onto glass coverslips and grown until confluent. For ciliogenesis
experiments, cells were serum starved using cell medium without fetal bovine
serum for 20 h. For immunofluorescence, cells were then fixed in 4% paraf-
ormaldehyde (PFA) for 10min, washed five times with PBS, treated with 0.05%
Triton X-100/PBS for 2min, washed five times with PBS, blocked 1 h using 4% BSA
in PBS and then incubated with the primary antibody. These were mouse mono-
clonal anti-acetylated tubulin 1:1,000 (IgG2b, clone 6-11-b1, Sigma), mouse
monoclonal anti-pericentrin IgG1 1:200 (mAbcam 28144, Abcam) or rabbit
polyclonal anti-IFT88 1:100 (13967-1-AP, Proteintech) overnight at 4 C. Cells
were then washed again five times with PBS and incubated with the appropriate
secondary antibodies: goat anti mouseIgG1 Alexa Fluor 647, goat anti-mouse
IgG2b Alexa Fluor 568 or goat anti-rabbit Alexa Fluor 488. Glass slides were then
washed five times in PBS, incubated with 4,6-diamidino-2-phenylindole (Molecular
Probes, Invitrogen) for 5min to obtain nuclear stain, washed five times in PBS and
then mounted in Vectashield (Vector Laboratories). For zebrafish immuno-
fluorescence studies, embryos were fixed at 24 h.p.f. in 4% PFA overnight, washed
five times in PBS containing 0.1% Triton X-100/PBS, incubated in 10% methanol
for 30min at  20 C, washed five times in PBS containing 0.1% Triton X-100 and
blocked with 5% BSA in PBS containing 0.1% Triton X-100 for 1 h. Embryos were
then incubated with the primary antibody mouse monoclonal anti-acetylated
tubulin 1:1,000 (IgG2b, clone 6-11-b1, Sigma) or mouse monoclonal anti-gamma
tubulin 1:250 (IgG1, Sigma) overnight at 4 C, washed five times in PBS containing
0.1% Triton X-100/PBS and then incubated with the appropriate secondary anti-
bodies: goat anti-mouse IgG1 Alexa Fluor 647 1:1,000 or goat anti-mouse IgG2b
Alexa Fluor 488 1:1,000 and 4,6-diamidino-2-phenylindole 1:25,000. All imaging
was performed using a Zeiss LSM710 confocal microscope.
Statistical analysis. Statistical analysis of cilia number and cilia length was per-
formed using Student’s t-test with statistical analysis performed using GraphPad
Prism.
Chlamydomonas cells and culture conditions. Chlamydomonas reinhardtii strain
137c (nit1, nit2, mtþ ) from the Chlamydomonas Resource Center (University of
Minnesota, St Paul, MN) was used as wild type. A54-e18 (nit1-1, ac17, sr1, mtþ ),
which is the parent of pf16-D2 (a double mutant of pf16 and tctex2b), and ‘pf16-D2
Resc. w/PF16,’ which is pf16-D2 rescued for the PF16 gene35,60, were from
Elizabeth Smith (Dartmouth College, NH). The dic5-1 insertional mutant was
generated by transforming g1 cells (nit1, NIT2, mtþ )61 with the 1.7-kb chimeric
aph70 0 gene cut by HindIII from the Hyg3 plasmid62, followed by backcrossing of a
transformant to wild-type cells. The D1bIC2-HA strain was generated by
transformation of dic5-1 with a gene encoding D1bIC2 with a C-terminal 3 HA
tag. Cells were grown in TAP medium63 or M medium I64 altered to have 0.0022M
KH2PO4 and 0.00171M K2HPO4; cultures were either aerated with 5% CO2 and
95% air or grown on 24-well plates.
Creation of DNA constructs for Chlamydomonas transformation. The wild-type
DIC5 gene was amplified by PCR from genomic DNA using primer pairs FAP133-
2 (50-TGTCCCGCTGCAGAGCAATG-30) and FAP133-3 (50-ACCCCG
CCTCCTTGTCCTTG-30). The blunt ends of the PCR product were modified by
A-tailing, that is, an extra A was added at the 30 ends of the product strands by Taq
polymerase. The modified PCR product was cloned into pGEM-T (Promega,
Madison, MI). To insert an HA tag into the DIC5 gene just before the stop codon,
primer pair FAP133-15 (50-GTAGAGTGGCAGTGCCGGC-30) and FAP133-16
(50-GCGTGAAGTTGCCGCGCA-30) was used to amplify the DIC5 gene and
vector. The PCR product was then ligated to the 3 HA fragment excised from
plasmid p3HA65 by SmaI.
Chlamydomonas immunoprecipitation and mass spectrometry. Flagella mem-
brane-plus-matrix fractions from wild-type and D1bIC2-HA cells were incubated
with the anti-HA affinity matrix (Roche Diagnostics GmbH) overnight. The beads
were washed three times with HMEK buffer (30mM HEPES, pH 7.4, 5mM
MgSO4, 0.5mM EGTA and 25mM KCl) plus 0.01% NP-40. Protease Inhibitor
Cocktail for plant cell and tissue extracts (Sigma-Aldrich) was added to prevent
protein degradation. SDS–PAGE sample loading buffer was used to elute the
proteins from the matrix. Proteins in the bound fractions from wild-type and
D1bIC2-HA samples were then separated by SDS–PAGE and stained with Silver
Stain Plus (Bio-Rad). Gel regions of interest were excised and analysed by mass
spectrometry at the Proteomics and Mass Spectrometry Facility, University of
Massachusetts Medical School, and the Vermont Genetics Network Proteomics
Facility, University of Vermont66,67.
Flagellar regeneration and analysis of IFT. For DIC imaging of steady-state
flagella and the subsequent analysis of IFT, live cells were immobilized in 1%
agarose and observed using an inverted microscope (Ti U; Nikon) equipped with
DIC optics59. To determine the kinetics of flagellar regeneration, cells were
deflagellated by the pH-shock method68 and allowed to regrow flagella under the
same conditions as before deflagellation. Aliquots of the cell suspensions were
removed at various times and fixed with 1% glutaraldehyde. Images of the fixed
cells were acquired with an AxioCam camera, AxioVision 3.1 software, and an
Axioskop 2 plus microscope (Zeiss). Flagellar lengths were measured using ImageJ
(http://rsb.info.nih.gov/ij/index.html). Images were processed using Adobe
Photoshop (Adobe Systems Incorporated, San Jose, CA).
References
1. Fliegauf, M., Benzing, T. & Omran, H. When cilia go bad: cilia defects and
ciliopathies. Nat. Rev. Mol. Cell. Biol. 8, 880–893 (2007).
2. Hildebrandt, F., Benzing, T. & Katsanis, N. Ciliopathies. N. Engl. J. Med. 364,
1533–1543 (2011).
3. Pedersen, L.B. & Rosenbaum, J.L. Intraflagellar transport (IFT) role in ciliary
assembly, resorption and signalling. Curr. Topics Dev. Biol. 85, 23–61 (2008).
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8074
10 NATURE COMMUNICATIONS | 6:7074 | DOI: 10.1038/ncomms8074 |www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
4. Patel-King, R.S., Gilberti, R.M., Hom, E.F. & King, S.M. WD60/FAP163 is a
dynein intermediate chain required for retrograde intraflagellar transport in
cilia. Mol. Biol. Cell 24, 2668–2677 (2013).
5. Hom, E.F.Y. et al. A unified taxonomy for ciliary dyneins. Cytoskeleton
(Hoboken NJ) 68, 555–565 (2011).
6. Pazour, G.J., Wilkerson, C.G. & Witman, G.B. A dynein light chain is essential
for the retrograde particle movement of intraflagellar transport (IFT). J. Cell
Biol. 141, 979–992 (1998).
7. Rompolas, P., Pedersen, L.B., Patel-King, R.S. & King, S.M. Chlamydomonas
FAP133 is a dynein intermediate chain associated with the retrograde
intraflagellar transport motor. J. Cell Sci. 120, 3653–3665 (2007).
8. Mikami, A. et al. Molecular structure of cytoplasmic dynein 2 and its
distribution in neuronal and ciliated cells. J. Cell Sci. 115, 4801–4808 (2002).
9. Grissom, P.M., Vaisberg, E.A. & McIntosh, J.R. Identification of a novel light
intermediate chain (D2LIC) for mammalian cytoplasmic dynein 2. Mol. Biol.
Cell 13, 817–829 (2002).
10. Pfister, K.K. et al. Genetic analysis of the cytoplasmic dynein subunit families.
PLoS Genet. 2, e1 (2006).
11. Goetz, S.C. & Anderson, K.V. The primary cilium: a signalling centre during
vertebrate development. Nat. Rev. Genet. 11, 331–344 (2010).
12. Huber, C. et al. WDR34 mutations that cause short-rib polydactyly syndrome
type III/severe asphyxiating thoracic dysplasia reveal a role for the NF-kappaB
pathway in cilia. Am. J. Hum. Genet. 93, 926–931 (2013).
13. Schmidts, M. et al. Mutations in the gene encoding IFT dynein complex
component WDR34 cause Jeune asphyxiating thoracic dystrophy. Am. J. Hum.
Genet. 93, 932–944 (2013).
14. McInerney-Leo, A.M. et al. Short-rib polydactyly and Jeune syndromes are
caused by mutations in WDR60. Am. J. Hum. Genet. 93, 515–523 (2013).
15. Dagoneau, N. et al. DYNC2H1 mutations cause asphyxiating thoracic
dystrophy and short rib-polydactyly syndrome, type III. Am. J. Hum. Genet. 84,
706–711 (2009).
16. Merrill, A.E. et al. Ciliary abnormalities due to defects in the retrograde
transport protein DYNC2H1 in short-rib polydactyly syndrome. Am. J. Hum.
Genet. 84, 542–549 (2009).
17. Huber, C. & Cormier-Daire, V. Ciliary disorder of the skeleton. Am. J. Med.
Genet. C Semin Med. Genet. 160C, 165–174 (2012).
18. Halbritter, J. et al. Defects in the IFT-B component IFT172 cause Jeune
and Mainzer-Saldino syndromes in humans. Am. J. Hum. Genet. 93, 915–925
(2013).
19. Tuz, K. et al.Mutations in CSPP1 cause primary cilia abnormalities and Joubert
syndrome with or without Jeune asphyxiating thoracic dystrophy. Am. J. Hum.
Genet. 94, 62–72 (2014).
20. Beales, P.L. et al. IFT80, which encodes a conserved intraflagellar transport
protein, is mutated in Jeune asphyxiating thoracic dystrophy. Nat. Genet. 39,
727–729 (2007).
21. Perrault, I. et al. Mainzer-Saldino syndrome is a ciliopathy caused by IFT140
mutations. Am. J. Hum. Genet. 90, 864–870 (2012).
22. Bredrup, C. et al. Ciliopathies with skeletal anomalies and renal insufficiency
due to mutations in the IFT-A gene WDR19. Am. J. Hum. Genet. 89, 634–643
(2011).
23. Davis, E.E. et al. TTC21B contributes both causal and modifying alleles across
the ciliopathy spectrum. Nat. Genet. 43, 189–196 (2011).
24. Shaheen, R. et al. A founder CEP120 mutation in Jeune asphyxiating thoracic
dystrophy expands the role of centriolar proteins in skeletal ciliopathies. Hum.
Mol. Genet. 24, 1410–1419 (2014).
25. Miller, K.A. et al. Cauli: a mouse strain with an Ift140 mutation that results
in a skeletal ciliopathy modelling Jeune syndrome. PLoS Genet. 9, e1003746
(2013).
26. Ocbina, P.J., Eggenschwiler, J.T., Moskowitz, I. & Anderson, K.V. Complex
interactions between genes controlling trafficking in primary cilia. Nat. Genet.
43, 547–553 (2011).
27. Schulte-Merker, S. & Stainier, D.Y.R. Out with the old, in with the new:
reassessing morpholino knockdowns in light of genome editing technology.
Development 141, 3103–3104 (2014).
28. Kok, F.O. et al. Reverse genetic screening reveals poor correlation between
morpholino-induced and mutant phenotypes in zebrafish. Dev. Cell 32, 97–108
(2015).
29. Tsujikawa, M. & Malicki, J. Intraflagellar transport genes are essential for
differentiation and survival of vertebrate sensory neurons. Neuron 42, 703–716
(2004).
30. Kramer-Zucker, A.G. et al. Cilia-driven fluid flow in the zebrafish pronephros,
brain and Kupffer’s vesicle is required for normal organogenesis. Development
132, 1907–1921 (2005).
31. Lunt, S.C., Haynes, T. & Perkins, B.D. Zebrafish ift57, ift88, and ift172
intraflagellar transport mutants disrupt cilia but do not affect hedgehog
signaling. Dev. Dyn. 238, 1744–1759 (2009).
32. Ryan, S. et al. Rapid identification of kidney cyst mutations by whole exome
sequencing in zebrafish. Development 140, 4445–4451 (2013).
33. Sun, Z. et al. A genetic screen in zebrafish identifies cilia genes as a principal
cause of cystic kidney. Development 131, 4085–4093 (2004).
34. Schmidts, M. et al. Exome sequencing identifies DYNC2H1 mutations as a
common cause of asphyxiating thoracic dystrophy (Jeune syndrome) without
major polydactyly, renal or retinal involvement. J. Med. Genet. 50, 309–323
(2013).
35. DiBella, L.M., Smith, E.F., Patel-King, R.S., Wakabayashi, K.-i. & King, S.M A
novel Tctex2-related light chain is required for stability of inner dynein arm I1
and motor function in the Chlamydomonas flagellum. J. Biol. Chem. 279,
21666–21676 (2004).
36. Pazour, G.J., Agrin, N., Leszyk, J. & Witman, G.B. Proteomic analysis of a
eukaryotic cilium. J. Cell Biol. 170, 103–113 (2005).
37. Yang, P. & Sale, W.S. The Mr 140,000 intermediate chain of Chlamydomonas
flagellar inner arm dynein is a WD-repeat protein implicated in dynein arm
anchoring. Mol. Biol. Cell 9, 3335–3349 (1998).
38. El Hokayem, J. et al. NEK1 and DYNC2H1 are both involved in short rib
polydactyly Majewski type but not in Beemer Langer cases. J. Med. Genet. 49,
227–233 (2012).
39. Baujat, G. et al. Asphyxiating thoracic dysplasia: clinical and molecular review
of 39 families. J. Med. Genet. 50, 91–98 (2013).
40. Pazour, G.J. et al. Chlamydomonas IFT88 and its mouse homologue, polycystic
kidney disease gene tg737, are required for assembly of cilia and flagella. J. Cell
Biol. 151, 709–718 (2000).
41. Marszalek, J.R., Ruiz-Lozano, P., Roberts, E., Chien, K.R. & Goldstein, L.S. Situs
inversus and embryonic ciliary morphogenesis defects in mouse mutants
lacking the KIF3A subunit of kinesin-II. Proc. Natl Acad. Sci. USA 96,
5043–5048 (1999).
42. Ashe, A. et al. Mutations in mouse Ift144 model the craniofacial, limb and rib
defects in skeletal ciliopathies. Hum. Mol. Genet. 21, 1808–1823 (2012).
43. Pazour, G.J., Dickert, B.L. & Witman, G.B. The DHC1b (DHC2) isoform of
cytoplasmic dynein is required for flagellar assembly. J. Cell Biol. 144, 473–481
(1999).
44. Porter, M.E., Bower, R., Knott, J.A., Byrd, P. & Dentler, W. Cytoplasmic dynein
heavy chain 1b is required for flagellar assembly in Chlamydomonas. Mol. Biol.
Cell 10, 693–712 (1999).
45. Hou, Y., Pazour, G.J. & Witman, G.B. A dynein light intermediate chain,
D1bLIC, is required for retrograde intraflagellar transport. Mol. Biol. Cell 15,
4382–4394 (2004).
46. Iomini, C., Babaev-Khaimov, V., Sassaroli, M. & Piperno, G. Protein particles
in Chlamydomonas flagella undergo a transport cycle consisting of four phases.
J. Cell Biol. 153, 13–24 (2001).
47. Engel, B.D. et al. The role of retrograde intraflagellar transport in flagellar
assembly, maintenance, and function. J. Cell Biol. 199, 151–167 (2012).
48. Lin, H., Nauman, N.P., Albee, A.J., Hsu, S. & Dutcher, S.K. New mutations in
flagellar motors identified by whole genome sequencing in Chlamydomonas.
Cilia 2, 14 (2013).
49. Asante, D., Stevenson, N.L. & Stephens, D.J Subunit composition of the human
cytoplasmic dynein-2 complex. J. Cell Sci. 127, 4774–4787 (2014).
50. Witman, G.B. in Dyneins: Structure, Biology and Disease. (ed. King, S.M.)
395–421 (Elsevier Inc., 2012).
51. King, S.M. in Dyneins: Structure, Biology and Disease. (ed. King, S.M.) 209–243
(Elsevier, Inc., 2012).
52. DiBella, L.M. et al. The Tctex1/Tctex2 class of dynein light chains.
Dimerization, differential expression, and interaction with the LC8 protein
family. J. Biol. Chem. 276, 14366–14373 (2001).
53. Goggolidou, P. et al. ATMIN is a transcriptional regulator of both lung
morphogenesis and ciliogenesis. Development 141, 3966–3977 (2014).
54. Lee, J.E. & Gleeson, J.G. A systems-biology approach to understanding the
ciliopathy disorders. Genome Med. 3, 59 (2011).
55. Khanna, H. et al. A common allele in RPGRIP1L is a modifier of retinal
degeneration in ciliopathies. Nat. Genet. 41, 739–745 (2009).
56. Kiesewetter, S. et al. A mutation in CFTR produces different phenotypes
depending on chromosomal background. Nat. Genet. 5, 274–278 (1993).
57. Brown, J.M., Fine, N.A., Pandiyan, G., Thazhath, R. & Gaertig, J. Hypoxia
regulates assembly of cilia in suppressors of Tetrahymena lacking an
intraflagellar transport subunit gene. Mol. Biol. Cell 14, 3192–3207 (2003).
58. Hou, Y. et al. Functional analysis of an individual IFT protein: IFT46 is
required for transport of outer dynein arms into flagella. J. Cell Biol. 176,
653–665 (2007).
59. Craige, B. et al. CEP290 tethers flagellar transition zone microtubules to the
membrane and regulates flagellar protein content. J. Cell Biol. 190, 927–940
(2010).
60. Smith, E.F. & Lefebvre, P.A. PF16 encodes a protein with armadillo repeats and
localizes to a single microtubule of the central apparatus in Chlamydomonas
flagella. J. Cell Biol. 132, 359–370 (1996).
61. Wilkerson, C.G., King, S.M., Koutoulis, A., Pazour, G.J. & Witman, G.B.
The 78,000 M(r) intermediate chain of Chlamydomonas outer arm dynein isa
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8074 ARTICLE
NATURE COMMUNICATIONS | 6:7074 | DOI: 10.1038/ncomms8074 |www.nature.com/naturecommunications 11
& 2015 Macmillan Publishers Limited. All rights reserved.
WD-repeat protein required for arm assembly. J. Cell Biol. 129, 169–178
(1995).
62. Berthold, P., Schmitt, R. & Mages, W. An engineered Streptomyces
hygroscopicus aph 7" gene mediates dominant resistance against hygromycin B
in Chlamydomonas reinhardtii. Protist 153, 401–412 (2002).
63. Gorman, D.S. & Levine, R.P. Cytochrome f and plastocyanin: their sequence in
the photosynthetic electron transport chain of Chlamydomonas reinhardi. Proc.
Natl Acad. Sci. USA 54, 1665–1669 (1965).
64. Sager, R. & Granick, S. Nutritional studies with Chlamydomonas reinhardi.
Ann N Y Acad. Sci. 56, 831–838 (1953).
65. Silflow, C.D. et al. The Vfl1 Protein in Chlamydomonas localizes in a
rotationally asymmetric pattern at the distal ends of the basal bodies. J. Cell
Biol. 153, 63–74 (2001).
66. Lechtreck, K.F., Luro, S., Awata, J. & Witman, G.B. HA-tagging of
putative flagellar proteins in Chlamydomonas reinhardtii identifies a novel
protein of intraflagellar transport complex B. Cell Motil. Cytoskeleton 66,
469–482 (2009).
67. Awata, J., Takada, S., Standley, C., Lechtreck, K.F., Bellve´, K.F., Pazour, G.J.,
Fogarty, K.E. & Witman, G.B. Nephrocystin-4 controls ciliary trafficking of
membrane and large soluble proteins at the transition zone. J. Cell Sci. 127,
4714–4727 (2014).
68. Witman, G.B., Carlson, K., Berliner, J. & Rosenbaum, J.L. Chlamydomonas
flagella. I. Isolation and electrophoretic analysis of microtubules, matrix,
membranes, and mastigonemes. J. Cell Biol. 54, 507–539 (1972).
Acknowledgements
We thank Sarah Bond (Genetics and Genomics Medicine Unit, ICH, UCL) for assistance
with Sanger Sequencing, Dr Elizabeth Smith (Dartmouth College) for providing
Chlamydomonas strains, and Dr John Leszyk (UMMS Proteomics and Mass Spectro-
metry Facility) and Dr Bin Deng (Vermont Genetics Network Proteomics Facility,
University of Vermont) for help with mass spectrometry. Andrew Phillips of HGMD
(Cardiff) assisted in nomenclature for the TCTEX1D2 exon 1–2 mutation. The
TCTEX1D2 SF-TAP construct was kindly provided by N. Katsanis and J. Willer. We are
grateful to the UK10K consortium, in particular, the Rare Diseases Group for making this
study possible; a full list of the UK10K investigators is available at http://www.uk10k.org/
publications_and_posters.html. Funding for UK10K was provided by the Wellcome
Trust under award WT091310. This research was supported by National Institutes of
Health (NIH) grants RO1 AR062651 and R01 AR066124 (to D.K.), R01 GM051293 (to
S.M.K.) and R37 GM030626 (to G.B.W.), by the Robert W. Booth Endowment at UMMS
(to G.B.W.) and by an NIH National Institute of General Medical Sciences Institutional
Development Award (IDeA) P20 GM103449 (to the Vermont Genetics Network). C.A.J.
acknowledges funding from a Sir Jules Thorn Award for Biomedical Research (JTA/09).
W.H. was supported by a stipend from the Rosetree’s Trust (grant A465). P.J.S. is funded
by the British Heart Foundation. H.K. acknowledges funding from the Scientific and
Technological Research Council of Turkey (TUBI˙TAK, grant number 112S398) sup-
ported by the overall consortium, CRANIRARE-2, the European Research Area Network
(ERA-Net) for research programmes on rare diseases (2011-2015). C.W. is supported by
an Australian National Health and Medical Research Council grant (APP1045464) and a
University of Queensland (UQ) Vice Chancellor’s Senior Research Fellowship, and
C.R.C. by a UQ International PhD Scholarship. M.U. and K.B. acknowledge funding
from FP7 grant agreement no. 278568, PRIMES. R.R. is supported by the Netherlands
Organization for Scientific Research (NWO Vici-865.12.005). M.U., P.L.B., R.R. and
C.A.J. acknowledge funding from the European Community’s Seventh Framework
Programme FP7/2009 under grant agreement no: 241955, SYSCILIA. M.S., P.L.B. and
R.R. acknowledge funding from the Dutch Kidney Foundation (CP11.18). P.L.B. and
H.M.M. are supported by the Great Ormond Street Hospital Children’s Charity. M.S. is
supported by an Action Medical Research UK Clinical Training Fellowship (RTF-1411),
a Radboud Excellence Initiative and Radboud Hypatia Fellowship, and acknowledges
funding from the German Research Foundation (DFG; Collaborative Research Center
1140, KIDGEM).
Author contributions
M.S., Y.H., H.M.M. and G.B.W. conceived the study and M.S., Y.H., S.M.K., C.W., R.R.,
H.M.M. and G.B.W. wrote the manuscript. M.S., Y.H., C.R.C., D.A.M., C.H., K.B., J.v.R.,
M.U., C.W., V.C.-D., R.R., H.M.M. and G.B.W. supervised experiments and were
involved in data interpretations. M.S. and S.P.T. performed whole-exome sequencing
analysis and M.S. performed zebrafish experiments and immunofluorescence analysis of
human fibroblasts. Y.H. performed Chlamydomonas experiments. S.M.K. prepared
antibodies against Chlamydomonas dynein light chains. C.R.C. performed immunopre-
cipitations of human TCTEX1D2. C.H. and J.-M.P. performed linkage analysis in human
subjects. M.P., Z.M.Y. and W.H. performed Sanger Sequencing of human samples.
D.A.M., J.v.R., S.E.C.v.B., S.J.F.L. and R.R. performed mammalian proteomics experi-
ments and proteomic bioinformatics analysis. K.B. and M.U. performed mammalian
proteomics mass spectrometry analysis. M.S., C.A.J., P.J.S., H.K., D.K., P.L.B. L.A.-G.,
V.C.-D. and H.M.M. were involved in patient enrolment. UK10K Consortium provided
whole-exome sequencing data.
Additional information
Supplementary Information accompanies this paper at http://www.nature.com/
naturecommunications
Competing financial interests: The authors declare no competing financial interests.
Reprints and permission information is available online at http://npg.nature.com/
reprintsandpermissions/
How to cite this article: Schmidts, M. et al. TCTEX1D2 mutations underlie Jeune
asphyxiating thoracic dystrophy with impaired retrograde intraflagellar transport.
Nat. Commun. 6:7074 doi: 10.1038/ncomms8074 (2015).
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated otherwise
in the credit line; if the material is not included under the Creative Commons license,
users will need to obtain permission from the license holder to reproduce the material.
To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
Saeed Al-Turki18,19, Carl Anderson18, Richard Anney20, Dinu Antony1, Jennifer Asimit18, Mohammad Ayub21,
Jeff Barrett18, Ineˆs Barroso18, Jamie Bentham22, Shoumo Bhattacharya22, Douglas Blackwood23,
Martin Bobrow24, Elena Bochukova25, Patrick Bolton26, Chris Boustred27, Gerome Breen26,28, Marie-Jo Brion27,
Andrew Brown18, Mattia Calissano29, Keren Carss18, Krishna Chatterjee25, Lu Chen18,30, Sebhattin Cirak29,
Peter Clapham18, Gail Clement31, Guy Coates18, David Collier32,33, Catherine Cosgrove22, Tony Cox18,
Nick Craddock34,35, Lucy Crooks18, Sarah Curran26, Allan Daly18, Petr Danecek18, George Davey Smith27,
Aaron Day-Williams18,36, Ian Day27, Richard Durbin18, Sarah Edkins18, Peter Ellis18, David Evans27,
I Sadaf Farooqi25, Ghazaleh Fatemifar27, David Fitzpatrick37, Paul Flicek38, Jamie Floyd18, A Reghan Foley29,
Chris Franklin18, Marta Futema39, Louise Gallagher19, Tom Gaunt27, Daniel Geschwind40, Celia Greenwood41,42,
Detelina Grozeva24, Xiaosen Guo43, Hugh Gurling44, Deborah Hart31, Audrey Hendricks18, Peter Holmans34,35,
Jie Huang18, Steve E. Humphries39, Matt Hurles18, Pirro Hysi31, David Jackson18, Yalda Jamshidi45,
David Jewell27, Joyce Chris18, Jane Kaye46, Thomas Keane18, John Kemp27, Karen Kennedy18, Alastair Kent47,
Anja Kolb-Kokocinski18, Genevieve Lachance31, Cordelia Langford18, Irene Lee48, Rui Li41,49, Yingrui Li43,
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8074
12 NATURE COMMUNICATIONS | 6:7074 | DOI: 10.1038/ncomms8074 |www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
Liu Ryan50, Jouko Lo¨nnqvist51, Margarida Lopes18,52, Daniel G. MacArthur18,53,54, Mangino Massimo31,
Jonathan Marchini55, John Maslen18, Shane McCarthy18, Peter McGuffin26, Andrew McIntosh6,
Andrew McKechanie6, Andrew McQuillin44, Yasin Memari18, Sarah Metrustry31, Josine Min27,
Alireza Moayyeri31, James Morris18, Dawn Muddyman18, Francesco Muntoni29, Kate Northstone27,
Michael O’Donovan34,35, Stephen O’Rahilly25, Alexandros Onoufriadis1, Karim Oualkacha56, Michael Owen34,35,
Aarno Palotie18,57, Kalliope Panoutsopoulou18, Victoria Parker25, Jeremy Parr58, Lavinia Paternoster27,
Tiina Paunio51, Felicity Payne18, John Perry31,52,59,60, Olli Pietilainen18,51,57, Vincent Plagnol61, Michael A. Quail18,
Lydia Quaye31, Lucy Raymond24, Karola Rehnstro¨m18, J. Brent Richards31,41,49, Sue Ring27,
Graham R. S. Ritchie18,38, David B. Savage25, Nadia Schoenmakers25, Robert K. Semple25, Eva Serra18,
Hashem Shihab27, So-Youn Shin18, David Skuse48, Kerrin Small31, Carol Smee18, Artigas Marı´a Soler62,
Nicole Soranzo18, Lorraine Southam18, Tim Spector31, Beate St Pourcain27, David St. Clair63, Jim Stalker18,
Gabriela Surdulescu31, Jaana Suvisaari51, Ioanna Tachmazidou18, Jing Tian43, Nic Timpson27, Martin Tobin62,
Ana Valdes31, Margriet van Kogelenberg18, Parthiban Vijayarangakannan18, Louise Wain62, Klaudia Walter18,
Jun Wang43, Kirsten Ward31, Ellie Wheeler18, Ros Whittall39, Hywel Williams34,35, Kathy Williamson37,
Scott G. Wilson31,64,65, Kim Wong18, Tamieka Whyte29, Xu ChangJiang41, Eleftheria Zeggini18,
Feng Zhang31 & Hou-Feng Zheng41,49
18 The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton CB10 1HH, Cambridge, UK. 19 Department of Pathology, King Abdulaziz
Medical City, Riyadh, Saudi Arabia. 20Department of Psychiatry, Trinity Centre for Health Sciences, St. James Hospital, James’s Street, Dublin 8, Ireland.
21 Durham University School of Medicine, Pharmacy and Health, Wolfson Research Institute, Queen’s Campus, Stockton-on-Tees TS17 6BH, UK.
22 Department of Cardiovascular Medicine and Wellcome Trust Centre for Human Genetics, Roosevelt Drive, Oxford OX3 7BN, UK. 23 Division of Psychiatry,
The University of Edinburgh, Royal Edinburgh Hospital, Edinburgh EH10 5HF, UK. 24Department of Medical Genetics, Cambridge Institute for Medical
Research, University of Cambridge, Cambridge CB2 2XY, UK. 25 University of Cambridge Metabolic Research Laboratories, and NIHR Cambridge Biomedical
Research Centre, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK. 26 Institute of Psychiatry, Kings College London, 16 De
Crespigny Park, London SE5 8AF, UK. 27MRC CAiTE Centre, School of Social and Community Medicine, University of Bristol, Oakfield House, Oakfield Grove,
Clifton, Bristol BS8 2BN, UK. 28 NIHR BRC for Mental Health, Institute of Psychiatry and SLaM NHS Trust, King’s College London, 16 De Crespigny Park,
London SE5 8AF, UK. 29Dubowitz Neuromuscular Centre, UCL Institute of child health & Great Ormond Street Hospital, London WC1N 1EH, UK.
30Department of Haematology, University of Cambridge, Long Road, Cambridge CB2 0PT, UK. 31 The Department of Twin Research & Genetic Epidemiology,
King’s College London, St Thomas’ Campus, Lambeth Palace Road, London SE1 7EH, UK. 32 Social, Genetic and Developmental Psychiatry Centre, Institute of
Psychiatry, King’s College London, Denmark Hill, London SE5 8AF, UK. 33 Lilly Research Laboratories, Eli Lilly & Co. Ltd., Erl Wood Manor, Sunninghill Road,
Windlesham, Surrey, UK. 34MRC Centre for Neuropsychiatric Genetics & Genomics, Institute of Psychological Medicine & Clinical Neurosciences, School of
Medicine, Cardiff University, Cardiff CF14 4XN. 35 Bart’s and the London School of Medicine and Dentistry, East Lindon NHS Foundation Trust, London, UK.
36Department of Translational Sciences, Biogen Idec, 14 Cambridge Center, Cambridge, MA 02142, USA. 37MRC Human Genetics Unit, MRC Institute of
Genetic and Molecular Medicine, at the University of Edinburgh, Western General Hospital, Edinburgh, EH4 2XU, UK. 38 European Bioinformatics Institute,
Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, UK. 39 Cardiovascular Genetics, BHF Laboratories, Rayne Building, Institute Cardiovascular
Sciences, University College London, London WC1E 6JJ, UK. 40UCLA David Geffen School of Medicine, Los Angeles, California, USA. 41 Departments of
Epidemiology, Biostatistics and Occupational Health, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
42 Department of Oncology, McGill University, Montreal, Quebec, Canada. 43 BGI-Shenzhen, Shenzhen 518083, China. 44Molecular Psychiatry Laboratory,
Mental Health Sciences Unit, University College London, 21 University St. Rockefeller Building, London WC1E 6BT, UK. 45Human Genetics Research Centre, St
George’s University of London, UK. 46HeLEX—Centre for Health, Law and Emerging Technologies, Department of Public Health, University of Oxford, Old
Road Campus, Oxford, OX3 7LF, UK. 47 Genetic Alliance UK, 4D Leroy House, 436 Essex Road, London N1 3QP, UK. 48 Behavioural and Brain Sciences Unit,
UCL Institute of Child Health, London, WC1N 1EH, UK. 49Departments of Medicine & Human Genetics, Lady Davis Institute, Jewish General Hospital, McGill
University, Montreal, Quebec, Canada.. 50 BGI-Europe, London. 51 National Institute for Health and Welfare (THL), Helsinki. 52Wellcome Trust Centre for
Human Genetics, Roosevelt Drive, Oxford, OX3 7BN, UK. 53Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston MA 02113,
USA. 54 Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge MA 02132, USA. 55Department of Statistics, University
of Oxford, 1 South Parks Road, Oxford OX1 3TG, UK. 56Department of Mathematics, Universite´ de Que´bec A` Montre´al, Montre´al, Que´bec, Canada.
57 Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland. 58 Institute of Neuroscience, Henry Wellcome Building for
Neuroecology, Newcastle University, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK. 59Genetics of Complex Traits, Peninsula Medical School,
University of Exeter, Exeter, UK. 60 Center for Statistical Genetics, University of Michigan, Ann Arbor, Michigan, USA. 61 University College London (UCL)
Genetics Institute (UGI) Gower Street, London, WC1E 6BT, UK. 62 Departments of Health Sciences and Genetics, University of Leicester, Leicester, UK.
63 Institute of Medical Sciences, University of Aberdeen, AB25 2ZD, UK. 64 School of Medicine and Pharmacology, University of Western Australia, Perth,
WA, Australia. 65Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, WA, Australia
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8074 ARTICLE
NATURE COMMUNICATIONS | 6:7074 | DOI: 10.1038/ncomms8074 |www.nature.com/naturecommunications 13
& 2015 Macmillan Publishers Limited. All rights reserved.
